CTCF is a key regulator of nuclear chromatin structure, chromatin organization and gene regulation. The impact of CTCF on transcriptional output is quite varied, ranging from repression, to transcriptional pausing and transactivation. The multifunctional nature of CTCF is mediated, in part, through differential association with protein partners having unique properties. We identified the general transcription factor TFII-I as an interacting partner of CTCF. To gain an understanding of the function of TFII-I in regulating gene expression and CTCF binding genome wide, we conducted microarray experiments following TFII-I knockdown and chromatin immunoprecipitation of CTCF followed by next generation sequencing (ChIP-seq) from the same TFII-I depleted cells. Here, we described the experimental design and the quality control and analysis that were performed on the dataset. The data is publicly available through the GEO database with accession number GSE60918. The interpretation and description of these data are included in a manuscript in revision (1).
Data format
ChIP-seq: Raw (Fastq) and processed (bed file and bedgraph file) Microarray: excel spreadsheet before and after normalization.
Experimental factors

Wehi231-CT vs Wehi231-TFII-I knockdown
Experimental features
Microarray gene expression profiling to identify genes that are regulated by TFII-I. ChIP-seq purpose was to map CTCF binding sites affected by TFII-I depletion. Consent NA Sample source location
NA
Direct link to deposited data
Deposited data are available here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE60918.
Experimental design, materials and methods
Cell line
The mouse B lymphocyte cell lines Wehi-231 expressing shRNA construct Control (Wehi-CT) or a shRNA construct directed against the transcription factor TFII-I (Wehi-TKII-I-KD) were used to investigate the effect of TFII-I depletion on global gene expression and CTCF binding.
Microarray and quality control
To identify genes regulated by TFII-I, we extracted total RNA from Wehi-CT and Wehi-TFII-I-KD from three independent samples. The quantity and the quality of the RNA samples were assessed by a Nanodrop spectrophotometer and Agilent Bioanalyser. Illumina BeadChIPs MouseWG-6 was used to perform expression analysis. Data preprocessing was carried out with Bioconductor package "lumi", and we used log2 transformation followed by quantile normalization [2, 3] . Quality controls were performed before (Fig. 1A) and after (Fig. 1B) microarray data preprocessing. Reproducibility between biological replicates was evaluated by calculating the correlation coefficient R 2 (see example of the scatter plot Fig. 1C and D) . Clustering of the microarray was performed to ensure correct segregation between Control and TFII-I knockdown samples (Fig. 1E) ATP6AP2  STARD13  GTF2I  ZFP219  MIB1  LIAS  CNR2  LMCD1  SFRS11  RAB8B  EGFL7  CYTIP  ZBTB17  RILPL2  CNR2  LSM14A  DEK  POLR3G  CYTH4  TBC1D10C  SHC1  STC2  LMCD1  ZFYVE26  MSH6  AATF  SLMO2  GSTT1  PFN1  FTL1  LRRC33  ANKRD49  HPRT1  NPM3  IL12A  NANS  D10ERTD610E  2310033F14RIK  BLK  AGPS  PLSCR1  POLE3  3300001G02RIK  2310008H09RIK  1600002K03RIK  GSTO1  AURKA  AF067061  RNF145  FAM178A  KHK  6330442E10RIK  TRUB2  1810026J23RIK  DDX24  TCIRG1  HAAO  VEGFB  CLEC2D  EBPL  ACTB  BST2  CREG1  BLVRB  GNAS  YBX3  1600012P17RIK  EIF2S2  RPN2  LOC629364  POLR2A  RBBP7  VPREB3  C730026J16  CALM3  PICK1  TMEM11  GUSB  ARPP19  MLLT4  CHFR  PLEKHA2  SERPINF1  MARCKS  HIST1H2BJ  AP3D1  PREI4  PANK4  GPR107  UBE2G1  PSMD8  CBR3  SEC63  RBM47  CEP120  DCPS  MT1  CKM  CDR2  SYNCRIP  VARS  LOC100044172  TWSG1  PDZD11  CDC5L  LCE1M  FCRL5  GPHN  DYNC1LI1  KEAP1  JAGN1  FCGR2B  RRM2  WDR68 EHD1 using Bioconductor package "limma" as shown with a volcano plot in Fig. 1F [4] . We identified 117 genes differentially regulated with a fold chance ≥ 2 and p-value ≤ 0.05 listed in Table 1 . As a confirmation of the knockdown efficiency, we found Gtf2i, the gene coding for TFII-I, being the gene the most down regulated in our data.
ChIP-seq
To identify the CTCF binding sites that were affected by TFII-I depletion, we carried two independent ChIP-seq assays CTCF in Wehi-CT and Wehi-TFII-I-KD cells with CTCF antibody. Briefly, cells were collected and crosslinked with 1% folmaldehyde in PBS for 10 min at room temperature. Crosslinking reaction was stooped with Glycerine 125 mM and cells were washed with PBS and stored at −80°C until assay was carried out. Cells were lysed and DNA sheered by sonication with cell lysis/ChIP buffer (0.25% NP-40, 0.25% Trinton-X, 0.25% Sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, 50 mM NaCl, 5 mM EDTA) for 15 s, 15 times. Lysed cells were centrifuged for 15 min at 14,000 rpm at 4°C and supernantant was collected. 1 mg of protein was precleared for 2 h with Protein G agarose beads (50% slurry blocked with salmon sperm) at 4°C. Immunoprecipitation was carried out by adding 2 μg of antibody and 30 μl of agarose G beads and nutated overnight at 4°C. After immunoprecipitation, beads were pelleted by centrifugation and were washed 4 times to remove unspecific binding using buffers with varying concentrations of salt. Buffers 1 to 3 contained 0.1% SDS, 1% Triton-X, 2 mM EDTA, 20 mM Tris pH 8.0 and 150 mM NaCl, 300 mM Nacl, 500 mM NaCl respectively. Buffer 4 contained 0.25 M LiCl, 1% NP-40, 1% Sodium deoxycholate, 1 mM EDTA and 10 mM Tris pH8.0. Two additional washes with TE were done to remove any residual buffer from the beads. Complexes bound to the beads were eluted with 500 μl of elution buffer (1% SDS, 1 mM EDTA, 50 mM Tris pH 8.0) at 65°C for 25 min with occasional vortexing. Beads were pelleted by centrifugation and supernatant was collected. Crosslink reversal was achieved by adding 0.2 mM NaCl at 65°C overnight. Next proteins (including DNA bound factors and antibodies) were degraded by a treatment with Proteinase K, carried at 45°C for 1 h and a second incubation of 15 min at 65°C. PCR purification kit (Qiagen) was used to retrieve the DNA following manufactured instruction and store at − 20°C. DNA was sent to the IRIC (Institut de Recherche en Immunologie et Cancérologie, Montreal, Canada) sequencing facility where both the library construction and sequencing (100bases, paired-end, HiSeq2000, Illumina) were carried out (Table 2) .
ChIP-seq quality control and analysis
Quality of the sequencing was assessed using FastQC software, an example is presented in Fig. 2A (http://www.bioinformatics. babraham.ac.uk/projects/fastqc/). Using FastX tool kit (http:// hannonlab.cshl.edu/fastx_toolkit/), DNA sequences obtained were trimmed to 45 bases, filtered for high quality scores (N30), and duplicates were removed before being aligned to the mouse genome (U.S. National Center for Biotechnology Information (NCBI) Build 37, July 2007, mm9) using the BWA algorithm [5] . Quality of the alignment was assessed using SAMStat and only the sequences with MAPQ score ≥ 30 were kept for further analysis (Fig. 2B and C) [6] . The model based analysis of ChIP-Seq peak-finding algorithm was used to identify peaks in Wehi-CT and Wehi-TFII-I-KD conditions using the default settings and an example of peak model obtain with MACS is presented in Fig. 2D [7] . Overlap for CTCF binding sites between biological replicates was assessed using the intersect function of bedtools [8] , the results are shown with Venn diagram (Fig. 2E) . HOMER was used to annotate CTCF peaks, determine their genomic distribution and generated the bedgraph files to visualize the results in UCSC Genome Browser (homer.salk.edu/). We used previously published CTCF ChIP-seq data available in the UCSC genome browser as controls for our dataset (Fig. 3) .
Discussion
Here, we described a dataset containing gene expression profiling using Illumina BeadChips (microarray) and ChIP-seq analysis of CTCF binding in mouse B cell lymphocyte cell lines expressing a shRNA construct against TFII-I, a general transcription factor. These data were generated to analyze the influence of TFII-I on the genomic targeting of the epigenetic regulatory protein CTCF, and understand how these two factors co-regulate gene transcription. With this dataset, we were able to show that TFII-I is important for targeting CTCF to a cohort of promoter regions where they co-operate to activate transcription. This finding sheds new light on how CTCF targeting at specific genomic regions can occur.
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